|

Gemcitabine & oxaliplatin Clinical Trials

3 actively recruiting trials across 1 location

Also known as: GEMOX

Pipeline

Phase 2: 3

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1
  • National Research Center for Hematology, Russia1
  • Massachusetts General Hospital1

Indications

  • Cancer3
  • Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)1
  • Relapsed or Refractory B-cell Lymphoma1
  • Relapsed/Refractory Large B-cell Lymphoma1
  • B-cell Lymphomas1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.